Michael Schmidt
Stock Analyst at Guggenheim
(4.83)
# 114
Out of 5,002 analysts
120
Total ratings
68.42%
Success rate
28.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMAB Genmab | Upgrades: Buy | $43 | $32.12 | +33.87% | 3 | Sep 23, 2025 | |
| INCY Incyte | Reiterates: Neutral | n/a | $86.28 | - | 6 | Sep 19, 2025 | |
| IMNM Immunome | Reiterates: Buy | $25 | $11.47 | +117.96% | 3 | Aug 25, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $125 → $30 | $8.00 | +275.00% | 4 | Aug 14, 2025 | |
| ADCT ADC Therapeutics | Reiterates: Buy | $10 | $3.98 | +151.26% | 6 | Aug 13, 2025 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $18 | $11.32 | +59.01% | 6 | Aug 13, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $10 → $12 | $3.47 | +245.82% | 5 | Aug 12, 2025 | |
| ONC BeOne Medicines AG | Maintains: Buy | $350 → $365 | $345.17 | +5.75% | 4 | Aug 7, 2025 | |
| ARVN Arvinas | Maintains: Buy | $16 → $15 | $9.27 | +61.81% | 6 | Aug 7, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $10 | $7.69 | +30.04% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $14.75 | +15.25% | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $45.70 | +75.05% | 4 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $18.83 | +138.98% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $15 | $17.07 | -12.13% | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $52 | $56.00 | -7.14% | 1 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $5.22 | +91.57% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $15.44 | +107.25% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $19.88 | -59.76% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $94.15 | +15.77% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $1.75 | $0.13 | +1,256.59% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $8.99 | +55.73% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $32.29 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $41.35 | +1.57% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.50 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $4.22 | +373.93% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.66 | +381.93% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $35.29 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.83 | +745.51% | 4 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.96 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.53 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.29 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $11.82 | +187.65% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $2.13 | +1,073.71% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $7.63 | +293.18% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $5.03 | +416.90% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.42 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $39.93 | +100.35% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $8.76 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $4.49 | +22.49% | 2 | Nov 7, 2017 |
Genmab
Sep 23, 2025
Upgrades: Buy
Price Target: $43
Current: $32.12
Upside: +33.87%
Incyte
Sep 19, 2025
Reiterates: Neutral
Price Target: n/a
Current: $86.28
Upside: -
Immunome
Aug 25, 2025
Reiterates: Buy
Price Target: $25
Current: $11.47
Upside: +117.96%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $125 → $30
Current: $8.00
Upside: +275.00%
ADC Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $3.98
Upside: +151.26%
ORIC Pharmaceuticals
Aug 13, 2025
Reiterates: Buy
Price Target: $18
Current: $11.32
Upside: +59.01%
Compass Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $3.47
Upside: +245.82%
BeOne Medicines AG
Aug 7, 2025
Maintains: Buy
Price Target: $350 → $365
Current: $345.17
Upside: +5.75%
Arvinas
Aug 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $9.27
Upside: +61.81%
Tango Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $10
Current: $7.69
Upside: +30.04%
Jul 8, 2025
Reiterates: Buy
Price Target: $17
Current: $14.75
Upside: +15.25%
Jun 25, 2025
Reiterates: Buy
Price Target: $80
Current: $45.70
Upside: +75.05%
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $18.83
Upside: +138.98%
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $17.07
Upside: -12.13%
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $56.00
Upside: -7.14%
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $5.22
Upside: +91.57%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $15.44
Upside: +107.25%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $19.88
Upside: -59.76%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $94.15
Upside: +15.77%
Mar 26, 2025
Maintains: Buy
Price Target: $3 → $1.75
Current: $0.13
Upside: +1,256.59%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $8.99
Upside: +55.73%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $32.29
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $41.35
Upside: +1.57%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.50
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $4.22
Upside: +373.93%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.66
Upside: +381.93%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $35.29
Upside: -
Sep 30, 2024
Upgrades: Buy
Price Target: $7
Current: $0.83
Upside: +745.51%
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.96
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.53
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.29
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $11.82
Upside: +187.65%
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $2.13
Upside: +1,073.71%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $7.63
Upside: +293.18%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $5.03
Upside: +416.90%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $3.42
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $39.93
Upside: +100.35%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $8.76
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $4.49
Upside: +22.49%